Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Membrane Technology

ËÄÉ«AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

Inhalation devices

ËÄÉ«AV’s inhalers offer our business partners access to simple, multipurpose, easy to use, globally competitive alternatives for inhalation delivery devices.

Page
Read more

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more